I think we will keep getting these announcements regularly as Apirx had many patents. The question from Renn about affording these trials is a good one. No, in my opinion we do not have enough funds to see all these trials to completion and unless there is a left field very near commercial opportunity, there is no new money in the future. Also not the time to take out any large loans, so I cannot see the BOD doing this either. Therefore I assume this is where Bob the builder comes in. It's his job to wine and dine Big Pharma and get them to jump into bed with us. The timing will need to be perfect as the funds dry up in a couple of years time. Management have always planned well ahead so I can guarantee they are not just dreaming to take these therapies to production.
There are big things brewing IMHO. That drawer I put my shares in.....might need 2 drawers! Good luck all.
IHL Price at posting:
24.0¢ Sentiment: Buy Disclosure: Held
